UAMY - Beautiful Setup with Key Changes in Management
New CEO is Mr. Evans Evans has served for 24 years as a Director of Novavax Inc., a NASDAQ listed (“NVAX”) clinical-stage vaccine biotechnology company (Covid-19 Vaccine) with a market capitalization in excess of $15 Billion, and previously served as Chairman, CEO and Lead Director.
Gary Evans has been buying the stock and now owns 1millin share @ price of $0.45
Volume is really low at the moment but Money flow has been consistently +ve
with Golden star indicator on a daily which is a really bullish signal.
Currently showing under consolidation
Little bit of volume can really send it
5million share buyback was announced by the company in latest 10Q
Gary Evans has been buying the stock and now owns 1millin share @ price of $0.45
Volume is really low at the moment but Money flow has been consistently +ve
with Golden star indicator on a daily which is a really bullish signal.
Currently showing under consolidation
Little bit of volume can really send it
5million share buyback was announced by the company in latest 10Q
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.